University of Queensland Diamantina Institute researchers Dr Roberta Mazzieri and Davide Moi have contributed to an important new gene therapy study published in Nature this week.
Two researchers from the University of Queensland Diamantina Institute, Dr Pascal Duijf and Dr Michelle Hill, have recently been awarded grants from the National Breast Cancer Foundation (NBCF) commencing January 2014.
A vaccine to treat non-Hodgkin’s lymphoma is one step closer after a University of Queensland Diamantina Institute researcher received a grant from the Leukaemia Foundation of Queensland.
The development of novel immune therapies and vaccines in Brisbane and Perth has been awarded an $11.8 million program grant from the National Health and Medical Research Council.
Dr Roberta Mazzieri at the University of Queensland Diamantina Institute is working with cancer researchers in Italy to develop a non-toxic treatment for human breast cancer that delivers an anti-cancer molecule directly to a tumour.
University of Queensland Diamantina Institute researcher Dr Liliana Endo Munoz has discovered that the cells responsible for normal bone destruction may help prevent bone cancer from spreading.
An international study that has identified new genetic regions involved in rheumatoid arthritis has shed light on existing medicines that could be effective in treating the disease.
A strategic partnership between The University of Queensland and global pharmaceutical company LEO Pharma will investigate the genetic causes of squamous cell carcinoma, the world’s second most common skin cancer.
A number of University of Queensland Diamantina Institute researchers have been announced as recipients of National Health and Medical Research Council (NHMRC) grants.
